Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06015126
Status:
RECRUITING
Last Update Posted:
2023-08-29
First Post:
2023-08-08
Brief Title:
Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Sponsor:
Yan Xue
Organization:
Xian International Medical Center Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-08
First Submit QC Date:
August 27 2023
Study First Post Date:
2023-08-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-27
Last Update Post Date:
2023-08-29
Last Update Post Date Type:
ACTUAL